Topical Therapy in Psoriasis

Psoriasis is a chronic condition that progresses in remitting and relapsing phases. Most of these patients have mild-to-moderate illness, which can be managed with topical medications or could be thought of as continuing therapy after remission. Potential therapeutic efficacy is offered, and systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, SK Shahriar, Manchanda, Yashpal, De, Abhishek, Das, Sudip, Kumar, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Symposium Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564191/
https://www.ncbi.nlm.nih.gov/pubmed/37822388
http://dx.doi.org/10.4103/ijd.ijd_422_23
_version_ 1785118453780185088
author Ahmed, SK Shahriar
Manchanda, Yashpal
De, Abhishek
Das, Sudip
Kumar, Rajesh
author_facet Ahmed, SK Shahriar
Manchanda, Yashpal
De, Abhishek
Das, Sudip
Kumar, Rajesh
author_sort Ahmed, SK Shahriar
collection PubMed
description Psoriasis is a chronic condition that progresses in remitting and relapsing phases. Most of these patients have mild-to-moderate illness, which can be managed with topical medications or could be thought of as continuing therapy after remission. Potential therapeutic efficacy is offered, and systemic treatment's negative side effects are constrained. Topical therapies have recently advanced in tandem with recent advancements in our understanding of psoriasis. To improve the quality of life of patients, appropriate knowledge and application of these topical agents are crucial.
format Online
Article
Text
id pubmed-10564191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-105641912023-10-11 Topical Therapy in Psoriasis Ahmed, SK Shahriar Manchanda, Yashpal De, Abhishek Das, Sudip Kumar, Rajesh Indian J Dermatol Symposium Article Psoriasis is a chronic condition that progresses in remitting and relapsing phases. Most of these patients have mild-to-moderate illness, which can be managed with topical medications or could be thought of as continuing therapy after remission. Potential therapeutic efficacy is offered, and systemic treatment's negative side effects are constrained. Topical therapies have recently advanced in tandem with recent advancements in our understanding of psoriasis. To improve the quality of life of patients, appropriate knowledge and application of these topical agents are crucial. Wolters Kluwer - Medknow 2023 /pmc/articles/PMC10564191/ /pubmed/37822388 http://dx.doi.org/10.4103/ijd.ijd_422_23 Text en Copyright: © 2023 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium Article
Ahmed, SK Shahriar
Manchanda, Yashpal
De, Abhishek
Das, Sudip
Kumar, Rajesh
Topical Therapy in Psoriasis
title Topical Therapy in Psoriasis
title_full Topical Therapy in Psoriasis
title_fullStr Topical Therapy in Psoriasis
title_full_unstemmed Topical Therapy in Psoriasis
title_short Topical Therapy in Psoriasis
title_sort topical therapy in psoriasis
topic Symposium Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564191/
https://www.ncbi.nlm.nih.gov/pubmed/37822388
http://dx.doi.org/10.4103/ijd.ijd_422_23
work_keys_str_mv AT ahmedskshahriar topicaltherapyinpsoriasis
AT manchandayashpal topicaltherapyinpsoriasis
AT deabhishek topicaltherapyinpsoriasis
AT dassudip topicaltherapyinpsoriasis
AT kumarrajesh topicaltherapyinpsoriasis

Ejemplares similares